Clinical Study
The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients
Table 2
Results of statistical comparisons of mRS score at 3 months between MLC601 and non-MLC601 patients.
| | | MLC601
() | Non-MLC601
() | Odds ratio
(95% CI) | value |
| | | (%) | (%) | | |
| | At 3 months | | | | | | mRS 0 to 2 | 21 (70%) | 17 (57%) | 1.79 (0.62 to 5.2) | 0.29 | | mRS 0 to 1 | 16 (53%) | 8 (27%) | 3.14 (1.1 to 9.27) | 0.038 |
|
|
